Skip to content

Insider · CIK 0001736359

Mock James M

cfoofficer

Files at MRNA (Moderna, Inc.). First filing Dec 2, 2024, latest Dec 2, 2024.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 1
$0 bought, $61k sold

Signals

This insider’s open-market buys and sells, scored.

ScoreSideCompanyValueSharesHoldings changePrice contextFiled
14Weaksell 310b5-1MRNA
Moderna, Inc.
$61k1,420-11%-

Transactions

Every row this insider has filed, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Dec 5, 2024MRNA
Moderna, Inc.
AGrant or award
Restricted Stock Unitsderivative
+188,761$0.00$0188,761Dec 6, 2024
Nov 27, 2024MRNA
Moderna, Inc.
MOption exercise
Common Stock10b5-1
+1,326--10,831Dec 2, 2024
Nov 27, 2024MRNA
Moderna, Inc.
MOption exercise
Common Stock10b5-1
+329--11,160Dec 2, 2024
Nov 27, 2024MRNA
Moderna, Inc.
MOption exercise
Common Stock10b5-1
+1,326--12,486Dec 2, 2024
Nov 29, 2024MRNA
Moderna, Inc.
SOpen-market sale
Common Stock10b5-1
-1,420$42.79$61k11,066Dec 2, 2024
Nov 27, 2024MRNA
Moderna, Inc.
MOption exercise
Performance Stock Unitsderivative10b5-1
-1,326$0.00$01,326Dec 2, 2024
Nov 27, 2024MRNA
Moderna, Inc.
MOption exercise
Restricted Stock Unitsderivative10b5-1
-329$0.00$02,959Dec 2, 2024
Nov 27, 2024MRNA
Moderna, Inc.
MOption exercise
Restricted Stock Unitsderivative10b5-1
-1,326$0.00$01,326Dec 2, 2024

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Mock James M: insider trades and track record | InsiderTell